Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning

References

• Williams B, Mancia G, Spiering W, et al. [2018 ESC/ESH Guidelines for the management of arterial hypertension]. Kardiol Pol. 2019;77:71–159.
   PubMed Web of Science ®Google Scholar
• Pharmaceutical Benefit Division. Australian Statistics on Medicines 2015. Canberra (ACT): Department of Health; 2016.
   Google Scholar
• Opie LH. Pharmacological differences between calcium antagonists. Eur Heart J. 1997;18(Suppl A):A71–9.
   PubMed Web of Science ®Google Scholar
• Gummin DD, Mowry JB, Spyker DA, et al. 2017 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 35th annual report. Clin Toxicol. 2018;56:1213–1415.
   PubMed Web of Science ®Google Scholar
• Abernethy DR. The pharmacokinetic profile of amlodipine. Am Heart J. 1989;118:1100–1103.
   PubMed Web of Science ®Google Scholar
• Meaney CJ, Sareh H, Hayes BD, et al. Intravenous lipid emulsion in the management of amlodipine overdose. Hosp Pharm. 2013;48:848–854.
   PubMedGoogle Scholar
• Adams BD, Browne WT. Amlodipine overdose causes prolonged calcium channel blocker toxicity. Am J Emerg Med. 1998;16:527–528.
   PubMed Web of Science ®Google Scholar
• Gerard L, Galloy AC, Capron A, et al. Mixed amlodipine/valsartan overdose treated by the molecular adsorbent recirculating system (MARS™). Clin Toxicol. 2015;53:573–577.
   Web of Science ®Google Scholar
• Smith SW, Ferguson KL, Hoffman RS, et al. Prolonged severe hypotension following combined amlodipine and valsartan ingestion. Clin Toxicol. 2008;46:470–474.
   PubMed Web of Science ®Google Scholar
• Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895–906.
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417–2428.
   PubMed Web of Science ®Google Scholar
• Taylor AA, Siragy H, Nesbitt S. Angiotensin receptor blockers: pharmacology, efficacy, and safety. J Clin Hypertens. 2011;13:677–686.
   PubMed Web of Science ®Google Scholar
• Herman LL, Bashir K. Angiotensin converting enzyme inhibitors (ACEI). Treasure Island (FL): StatPearls; 2019.
   Google Scholar
• Balit CR, Gilmore SP, Isbister GK. Unintentional paediatric ingestions of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists. J Paediatr Child Health. 2007;43:686–688.
   PubMed Web of Science ®Google Scholar
• Lip GY, Ferner RE. Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors. J Hum Hypertens. 1995;9:711–715.
   PubMed Web of Science ®Google Scholar
• Varughese A, Taylor AA, Nelson EB. Consequences of angiotensin-converting enzyme inhibitor overdose. Am J Hypertens. 1989;2:355–357.
   PubMed Web of Science ®Google Scholar
• Prasa D, Hoffmann-Walbeck P, Barth S, et al. Angiotensin II antagonists – an assessment of their acute toxicity. Clin Toxicol. 2013;51:429–434.
   Web of Science ®Google Scholar
• Brunette-Lawrey E, Croft F. Losartan and amlodipine overdose – case report of a patient with anuric renal failure prior to the onset of hypotension. N Z Med J. 2016;129:84–86.
   PubMed Web of Science ®Google Scholar
• Chan BS, Becker T, Chiew AL, et al. Vasoplegic shock treated with methylene blue complicated by severe serotonin syndrome. J Med Toxicol. 2018;14:100–103.
   PubMed Web of Science ®Google Scholar
• Haughey R, Vernick W, Gutsche J, et al. Use of veno-venous extracorporeal membrane oxygenation to treat severe combined calcium channel blocker and angiotensin converting enzyme inhibitor overdose. Perfusion. 2019;34:167–169.
   PubMed Web of Science ®Google Scholar
• Plumb JO, Stewart C, Eddleston M, et al. Prolonged refractory hypotension following combined amlodipine and losartan ingestion responsive to metaraminol. Case Rep Med. 2011;2011:283672.
   PubMedGoogle Scholar
• Tovar JL, Bujons I, Ruiz JC, et al. Treatment of severe combined overdose of calcium antagonists and converting enzyme inhibitors with angiotensin II. Nephron. 1997;77:239.
   PubMed Web of Science ®Google Scholar
• Weinberg RL, Bouchard NC, Abrams DC, et al. Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose. Perfusion. 2014;29:53–56.
   PubMed Web of Science ®Google Scholar
• Wood DM, Wright KD, Jones AL, et al. Metaraminol (Aramine) in the management of a significant amlodipine overdose. Hum Exp Toxicol. 2005;24:377–381.
   PubMed Web of Science ®Google Scholar
• Cairns R, Brown JA, Buckley NA. The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia’s largest poisons centre. Addiction. 2016;111:1848–1853.
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs, 2020. Oslo (Norway): WHO Collaborating Centre for Drug Statistics Methodology; 2019.
   Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–377.
   PubMed Web of Science ®Google Scholar
• Augenstein WL, Kulig KW, Rumack BH. Captopril overdose resulting in hypotension. JAMA. 1988;259:3302–3305.
   PubMed Web of Science ®Google Scholar
• Waeber B, Nussberger J, Brunner HR. Self poisoning with enalapril. Br Med J. 1984;288:287–288.
   PubMed Web of Science ®Google Scholar
• Baffoni L, Durante V, Grossi M. Acute pancreatitis induced by telmisartan overdose. Ann Pharmacother. 2004;38:1088.
   PubMed Web of Science ®Google Scholar
• Dawson AH, Harvey D, Smith AJ, et al. Lisinopril overdose. Lancet. 1990;335:487–488.
   PubMed Web of Science ®Google Scholar
• Christie GA, Lucas C, Bateman DN, et al. Redefining the ACE-inhibitor dose–response relationship: substantial blood pressure lowering after massive doses. Eur J Clin Pharmacol. 2006;62:989–993.
   PubMed Web of Science ®Google Scholar
• Skolnik NS, Beck JD, Clark M. Combination antihypertensive drugs: recommendations for use. Am Fam Physician. 2000;61:3049–3056.
   PubMed Web of Science ®Google Scholar
• Gennari C, Nami R, Pavese G, et al. Calcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension. Cardiovasc Drugs Ther. 1989;3 Suppl 1:319–325.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Wunderink RG, Szerlip H, et al. Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock. Crit Care. 2020;24:43.
   PubMed Web of Science ®Google Scholar
• Xu B, Xiao-Hong L, Lin G, et al. Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism. Br J Pharmacol. 2002;136:375–382.
   PubMed Web of Science ®Google Scholar
• Lenasi H, Kohlstedt K, Fichtlscherer B, et al. Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495. Cardiovasc Res. 2003;59:844–853.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation. 1998;97:576–580.
   PubMed Web of Science ®Google Scholar
• Zhang XP, Loke KE, Mital S, et al. Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R + enantiomer of amlodipine. J Cardiovasc Pharmacol. 2002;39:208–214.
   PubMed Web of Science ®Google Scholar
• Mason RP, Jacob RF, Kubant R, et al. Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants. Br J Clin Pharmacol. 2012;74:141–146.
   PubMed Web of Science ®Google Scholar
• Imanishi T, Kuroi A, Ikejima H, et al. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits. Hypertens Res. 2008;31:575–584.
   PubMed Web of Science ®Google Scholar
• Hoffman RS. Understanding the limitations of retrospective analyses of poison center data. Clin Toxicol (Phila)). 2007;45:943–945.
   PubMed Web of Science ®Google Scholar
• Balit CR, Isbister GK, Hackett LP, et al. Quetiapine poisoning: a case series. Ann Emerg Med. 2003;42:751–758.
   PubMed Web of Science ®Google Scholar